Cozart raises $4 million in the drugs-of-abuse race
This article was originally published in Clinica
UK private diagnostic company Cozart plans to expand its R&D and boost sales and marketing in order to export to new territories, following the investment of £3.1 million ($4.3 million) raised in a recent private funding round.
You may also be interested in...
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.
The race is now on to get formal adoption of European Commission proposal postponing the MDR by one year and allowing more devices on the market more quickly. But potential hurdles are in the way as experts advise caution.